XML 29 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
CASH FLOWS USED IN OPERATING ACTIVITIES:    
Net loss $ (27,097) $ (27,817)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 33 13
Amortization of premium (accretion of discount) on marketable securities, net   14
Stock-based compensation expense 1,815 785
Research and development expense settled in stock 2,717 7,255
Change in fair value of other current assets, warrant liability and other liability 505 (10,074)
Non-cash interest 127 215
Non-cash portion of loss on retirement of note payable 57  
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets (1,420) 647
Other long-term assets (150)  
Accounts payable 888 1,018
Accrued expenses and other current liabilities 3,254 8,240
Net cash used in operating activities (19,271) (19,704)
CASH FLOWS USED IN INVESTING ACTIVITIES:    
Purchases of property and equipment (29)  
Purchases of marketable securities (30,649) (17,070)
Sales and maturities of marketable securities   4,000
Net cash used in investing activities (30,678) (13,070)
CASH FLOWS PROVIDED BY FINANCING ACTIVITIES:    
Proceeds from exercise of stock options   13
Proceeds from note payable, net 20,568  
Payments on note payable (13,156) (3,938)
Proceeds from the issuance of common stock, net 51,332  
Deferred financing costs (95)  
Proceeds from the issuance of preferred stock, net 27,368 42,870
Net cash provided by financing activities 86,017 38,945
NET INCREASE IN CASH AND CASH EQUIVALENTS 36,068 6,171
CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR 12,303 18,653
CASH AND CASH EQUIVALENTS AT END OF PERIOD 48,371 24,824
SUPPLEMENTAL DISCLOSURES:    
Cash paid for interest 555 998
NON-CASH FINANCING ACTIVITIES:    
Accretion of dividends on preferred stock 9,000 7,950
Fair value of Series A-6 convertible preferred stock issued as settlement of liability 10,109  
Fair value of warrants issued 1,511 1,356
Initial public offering costs included in accrued expenses and other current liabilities 1,182  
Reclassification of preferred stock to common stock $ 298,063